Patent · US Active

Pt (IV) derivatives and nanocarriers comprising them

US10239903B2 · kind B2 · utility

1Cited by
2References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 30, 2015
Grant dateMar 26, 2019
Priority date
Expiry dateApr 30, 2035

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P35/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided are Pt (IV) lipophilic derivatives for improved drug performance in cancer therapy, as well as nanocarriers including the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.